SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-105876
Filing Date
2024-04-23
Accepted
2024-04-23 07:01:58
Documents
7
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A d708745ddef14a.htm DEF 14A 811851
2 GRAPHIC g708745g04g04.jpg GRAPHIC 23157
3 GRAPHIC g708745g38g38.jpg GRAPHIC 105750
4 GRAPHIC g708745g39g39.jpg GRAPHIC 104083
5 GRAPHIC g708745g88z98.jpg GRAPHIC 51620
6 GRAPHIC g708745g90g90.jpg GRAPHIC 335052
7 GRAPHIC g708745g91g91.jpg GRAPHIC 186331
  Complete submission text file 0001193125-24-105876.txt   1921311
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37813 | Film No.: 24862668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)